Neil J. Gallagher, M.D., Ph.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get FHTX alerts

About Neil J. Gallagher, M.D., Ph.D.

Neil J. Gallagher, M.D., Ph.D. is recorded as Board Member at Foghorn Therapeutics Inc. (FHTX) since May 1, 2025. Foghorn Therapeutics Inc. reported in an 8-K filed May 1, 2025 that Neil J. Gallagher, M.D., Ph.D. was appointed Class II director, effective May 1, 2025. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer) and 7 others.

“Also on April 25, 2025, the Company's Board, upon recommendation of the Nominating Committee, appointed Neil J. Gallagher, M.D., Ph.D. to the Board, effective May 1, 2025.”

Foghorn Therapeutics Inc. Form 8-K, filed May 1, 2025 · Read the filing

Affiliation history

Foghorn Therapeutics Inc. (FHTX)
Board Member

SEC 8-K

Current
2025-05-01–present

Company network

Foghorn Therapeutics Inc.

FHTX

Current role

Biotechnology · Healthcare

Board Member

2025-05-01–present

Leadership on record at Foghorn Therapeutics Inc.

Adrian Gottschalk CEO, Board Member
Jeff Sacher CFO
Kristian F. Humer CFO, Chief Accounting Officer
Ryan D. Maynard CFO
Ryan Maynard CFO
Stephen J. DiPalma CFO
Steven Bellon CTO
B. Lynne Parshall Board Member
Ian F. Smith Board Member
Stuart Duty Board Member

Recent activity

Executive change Appointed: Class II director Foghorn Therapeutics Inc. (FHTX)
2025-05-01